Substantial Shareholding

RNS Number:6865B
Bespak PLC
19 April 2006


For immediate release                                           19 April 2006


                                    Bespak plc

                                  ('the Company')

                            Substantial Shareholding


Bespak plc (LSE: BPK), a leader in specialty medical devices, reports, further
to a letter received 19 April 2006, that the AEGON UK plc Group of Companies
and its subsidiaries sold 50,000 Ordinary Shares of 10 pence in the Company or
0.21% of their issued class.


Following this transaction, AEGON UK plc and its subsidiaries now own 818,522
Ordinary Shares of 10 pence or 2.92% of their issued class as follows:


Subsidiary                                           Number of shares
Chase Nominees Limited                               818,522


                                      ENDS

For further information please call:


Bespak plc
Mark Throdahl - Chief Executive                          [phone]
Martin Hopcroft - Group Finance Director

Buchanan Communications                                     [phone]
Tim Thompson / Mary-Jane Johnson / Elly Williamson



Notes for Editors:



About Bespak plc

Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings.  Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes.  The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on the
Official List of the London Stock Exchange (LSE: BPK).  For more information,
please visit www.bespak.com.






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLILFLESFIALIR